Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance. Benzinga · Dec 4, 2024
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock? Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects. Benzinga · Dec 4, 2024
Ayr Wellness: Analyst Reduces Price Target And Stays Neutral After Q3 Results On Thursday, Ayr Wellness Inc. (CSE: AYR.A) (OTCQX: AYRWF) reported its financial results for the third quarter that ended September 30, 2022, with revenue of $119.6 million Benzinga · Nov 11, 2022
Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) recently reported its financial results for the third quarter that ended September 30, 2022 (&ldquo Benzinga · Nov 9, 2022
Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral Acreage Holdings, Inc. (OTCQX: ACRDF) reported its financial results on Monday for the third quarter that ended September 30, 2022 (“Q3 2022”). Benzinga · Nov 9, 2022
Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception Canopy Growth Corporation (NASDAQ: CGC) Benzinga · Nov 7, 2022
Green Thumb Industries' Positive Q3 Report Compels Analyst To Place It Among 'Best-Managed MSOs' Green Thumb Industries (OTCQX: GTBIF) reported Benzinga · Nov 3, 2022
What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark. Benzinga · Oct 22, 2022
Aurora & Tilray Better Positioned Than Other Cannabis Operators For Germany's Imminent Market Launch, Here's Why A draft of the German government's cannabis legalization measure, which was leaked on Wednesday, indicates the EU country is getting close to legalizing retail distribution, possession a Benzinga · Oct 20, 2022
Columbia Care: Updated Estimates Ahead Of Acquisition By Cresco Labs The Analyst Benzinga · Oct 7, 2022
Why Is Curaleaf One Of The Best-Positioned Cannabis Multi-State Operators? Curaleaf Holdings, Inc. (OTCQX: CURLF) posted its financial results Monday for the second quarter ended June 30, 2022. Benzinga · Aug 9, 2022
Analysts Going Hard On Tilray, Slashing Price Targets; How Much Adj. EBITDA Really Improved? Tilray Brands, Inc. Benzinga · Aug 2, 2022
2Q Canada Recreational Cannabis Market Analysis: +21 YoY Growth Outperforming The U.S. In a recent analyst note, Cantor Fitzgerald's Pablo Zuanic gave an overview of the Canadian recreational cannabis market in the second quarter of 2022, according to data collected by Hifyre, a leading in-shop and online digital toolset for cannabis dispensaries. Benzinga · Jul 14, 2022
Why Higher Prices Aren't Always A Bad Thing: This Analyst Explains The Canadian Cannabis Flower Market Cannabis flower prices seem to be inversely proportional to their sales, at least according to data provided by Seattle-based Headset which tracks six recreational cannabis markets, including California, Colorado, Michigan, Nevada, Oregon and Washington state. Benzinga · Jul 8, 2022
Benzinga · Apr 6, 2022 Curaleaf Holdings To Report Q1 Results In Anticipation Of New Jersey Legal Cannabis Launch Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) will report its financial and operating results for the first quarter ended March 31, 2022, after market close on May 9, 2022.